Funding Rounds
Saga Diagnostics Series A (2019, $4M)
Saga DiagnosticsLiquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.
Summary
Stage: Series A
Raised Amount: $4.23M
Raised Date: 2019-01-01
